Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Nevada

54 recruiting clinical trials across 5 cities in Nevada (NV). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
54
Total Trials
54
Recruiting Now
5
Cities
20
Conditions

Recruiting Trials in Nevada

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT03695978

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A...

International, post-authorisation non-interventional study to evaluate real-life effectiveness, safety and utilisation patterns of Octapharma's FVIII concentrates Nuwiq, Octanate,...

Sponsor: OctapharmaEnrolling: 20020 locations
Haemophilia A
RECRUITINGNCT04165109

Trial-Ready Cohort-Down Syndrome (TRC-DS)

The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC),...

Sponsor: University of Southern CaliforniaEnrolling: 55020 locations
Down SyndromeAlzheimer DiseaseDementia
RECRUITINGNCT04363684

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390;...

Sponsor: Mayo ClinicEnrolling: 210020 locations
Frontotemporal Lobar Degeneration (FTLD)Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)+11
RECRUITINGPhase 2 / Phase 3NCT04442022

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With...

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive...

Sponsor: Karyopharm Therapeutics INCEnrolling: 50120 locations
Relapsed/Refractory Diffuse Large B-cell Lymphoma
RECRUITINGPhase 3NCT05126277

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With...

This trial will evaluate efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 weeks (q12w) compared to placebo, in combination...

Sponsor: Novartis PharmaceuticalsEnrolling: 46220 locations
Lupus Nephritis
RECRUITINGPhase 1 / Phase 2NCT05197270

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and...

Sponsor: 4D Molecular TherapeuticsEnrolling: 21520 locations
Neovascular (Wet) Age-Related Macular Degeneration
RECRUITINGNCT05297734

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC)...

Sponsor: Stanford UniversityEnrolling: 299617 locations
End of LifeCancer
RECRUITINGNCT05516862

Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma

This study seeks to verify that a specific acupuncture treatment is effective at reducing symptoms of neuropsychiatric trauma found in those diagnosed with Post-Traumatic Stress...

Sponsor: Paul CrawfordEnrolling: 751 location
PTSDPost Traumatic Stress DisorderAcupuncture
RECRUITINGPhase 2NCT05626114

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With...

This study will evaluate the success and safety of subretinal surgical delivery as well as the preliminary activity of OpRegen in participants with geographic atrophy (GA)...

Sponsor: Genentech, INC.Enrolling: 6017 locations
Geographic Atrophy
RECRUITINGNCT05776225

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial...

Sponsor: United TherapeuticsEnrolling: 30020 locations
Interstitial Lung DiseasePulmonary Hypertension
RECRUITINGNCT05854524

Exercise Neuroprotection in Parkinson's Disease

The purpose of this study is to explore the relationships of exercise on inflammation in the body of older adults and people with Parkinson's disease (PD). This is important...

Sponsor: University of Nevada, Las VegasEnrolling: 901 location
Parkinson Disease
RECRUITINGPhase 3NCT05894239

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With...

This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with...

Sponsor: Hoffmann-La RocheEnrolling: 23020 locations
Metastatic Breast Cancer
RECRUITINGPhase 2NCT06088979

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

Phase 2b trial of TOUR006 in Thyroid Eye Disease (TED) to evaluate 20mg and 50mg doses against placebo given by a subcutaneous injection every eight weeks to TED patients who are...

Sponsor: Tourmaline Bio, Inc.Enrolling: 8120 locations
Thyroid Eye Disease
RECRUITINGPhase 3NCT06094010

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission...

This study consists of two parts: Part A Surveillance and Part B Transmission. The main purpose of Part A is to evaluate the prevalence of pre-dose and treatment-emergent amino...

Sponsor: Hoffmann-La RocheEnrolling: 75020 locations
Influenza
RECRUITINGNCT06122077

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from...

Sponsor: Freenome Holdings Inc.Enrolling: 2000020 locations
Lung Cancer Diagnosis
RECRUITINGPhase 2NCT06254950

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to...

The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants...

Sponsor: TakedaEnrolling: 20720 locations
Ulcerative Colitis
RECRUITINGPhase 1 / Phase 2NCT06401044

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of...

Sponsor: AmgenEnrolling: 8820 locations
Thyroid Eye Disease
RECRUITINGNCT06455475

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

This randomized controlled study evaluates the adjuvant use of Derm-Maxx in patients with diabetic foot ulcers

Sponsor: Capsicure, LLCEnrolling: 15011 locations
Diabetic Foot Ulcer
RECRUITINGNCT06486454

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users...

The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how...

Sponsor: HistoSonics, INC.Enrolling: 500020 locations
Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2
RECRUITINGPhase 4NCT06529406

Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

A multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy.

Sponsor: University of Colorado, DenverEnrolling: 1003 locations
Relapsing Multiple Sclerosis
RECRUITINGPhase 3NCT06561386

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for...

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV...

Sponsor: Bristol-Myers SquibbEnrolling: 100020 locations
Non-small Cell Lung Cancer
RECRUITINGNCT06566716

A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass

Ovarian cancer is a serious health risk with the highest death rate among gynecological cancers. Unfortunately, it's only possible to definitively diagnose ovarian cancer after...

Sponsor: Cleo Diagnostics LtdEnrolling: 10008 locations
Ovarian Neoplasms
RECRUITINGNCT06571669

BOOM-IBD2 Pivotal Clinical Trial

The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.

Sponsor: Boomerang MedicalEnrolling: 13710 locations
Ulcerative ColitisInflammatory Bowel Diseases
RECRUITINGPhase 1NCT06576271

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and...

This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active SLE...

Sponsor: GlaxoSmithKlineEnrolling: 14220 locations
Systemic Lupus Erythematosus
RECRUITINGPhase 4NCT06594068

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users (PRIMULA Lac) is a Post Marketing Requirements (PMR) study designed to fulfill the...

Sponsor: AstraZenecaEnrolling: 161 location
Systemic Lupus Erythematosus
RECRUITINGNCT06605183

10,000 Step Club: Community Walking Program for People with Parkinson's Disease

The 10,000 Step Club (10KSTC) is a 6-month community walking program for people with Parkinson's disease (PwP) and their caregivers in Las Vegas, Nevada (LV). This program will...

Sponsor: University of Nevada, Las VegasEnrolling: 601 location
Parkinson Disease
RECRUITINGPhase 2NCT06613698

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70...

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.

Sponsor: GlaxoSmithKlineEnrolling: 39320 locations
Liver Diseases, Alcoholic
RECRUITINGPhase 3NCT06641466

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual...

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in...

Sponsor: PfizerEnrolling: 72320 locations
Menstrual Migraine
RECRUITINGPhase 2NCT06656416

ALTO-100 in Bipolar Disorder With Depression (BD-D)

The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II...

Sponsor: Alto NeuroscienceEnrolling: 20020 locations
Bipolar Disorder I or II With a Major Depressive Episode
RECRUITINGPhase 1NCT06657144

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced...

The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in...

Sponsor: Coherus Oncology, INC.Enrolling: 15420 locations
Metastatic Solid TumorAdvanced Solid Tumor

Showing 30 of 54 trials in Nevada. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 54 clinical trials actively recruiting participants in Nevada. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Nevada include Parkinson Disease, Thyroid Eye Disease, Ulcerative Colitis, Systemic Lupus Erythematosus, Schizophrenia. Each has multiple active trials across research centers in the state.

Major trial sites in Nevada include Las Vegas, Reno, Nellis Air Force Base, Henderson, North Las Vegas. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.